Tag Archive for Ann LaCasce

Live Web Chat: Answering Questions on New Lymphoma Treatments

Share

Ann LaCasce, MD, a medical oncologist in the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answered a variety of questions about Hodgkin and non-Hodgkin lymphoma during a live web chat hosted by Dana-Farber last month.

Read more

Chat Live with a Dana-Farber Lymphoma Expert

Share

Lymphoma: How do we treat it? Where are future therapies headed?

Ann LaCasce, MD

On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page.

LaCasce will discuss current treatment options as well as future therapies for lymphoma.

If you have a question for Dr. LaCasce, email webchats@dfci.harvard.edu. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat.

Bookmark the webchat video page and tune in live on Dec. 18 at 1 p.m. EST. You can also add the event to your calendar or RSVP on Facebook.

Clinical Trials and the Future of Lymphoma Treatment

Share

Current lymphoma therapies are a far cry from the mustard gas used more than 50 years ago. More treatment options, including ones that may be more effective and less toxic, are being studied in ongoing clinical trials.

“Clinical trials really are the future of lymphoma treatment,” says Ann LaCasce, MD, a medical oncologist in the Adult Lymphoma Program at Dana-Farber/Brigham and Women’s Cancer Center.

Read more